Related Experiment Video
Updated: Jul 7, 2026
11:17
Thoracoscopic Extended Right Middle Plus Lower Sleeve Lobectomy for Non-Small-Cell Lung Cancer
Published on: February 27, 2026
Surgical treatment for pulmonary artery sarcoma
Hong Kwan Kim1, Yong Soo Choi, Kwhanmien Kim
1Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
Summary
Surgical resection of pulmonary artery sarcoma using cardiopulmonary bypass offers excellent early outcomes. Complete tumor removal, confirmed by frozen section biopsy, is crucial for improving survival in this rare cancer.
Area of Science:
- Cardiovascular Surgery
- Surgical Oncology
- Thoracic Oncology
Background:
- Pulmonary artery sarcoma is a rare and aggressive malignancy with a poor prognosis.
- Surgical management aims for complete tumor resection to improve patient outcomes.
Observation:
- Nine patients with pulmonary artery sarcoma underwent surgical resection between 1999 and 2007.
- Seven patients received hypothermic cardiopulmonary bypass to facilitate radical tumor removal.
- Intraoperative frozen section biopsy confirmed resection margins.
Findings:
- No in-hospital mortality or significant operative complications were observed.
- The median survival time was 17.6 months, with recurrence (local or metastatic) observed in six patients.
- Late outcomes were comparable to previous reports, suggesting surgical intervention is viable.
Implications:
- Complete resection, aided by cardiopulmonary bypass and confirmed by intraoperative margin assessment, is vital for managing pulmonary artery sarcoma.
- This approach may improve survival rates for patients with this rare tumor.
- Further research into neoadjuvant/adjuvant therapies alongside surgical management is warranted.
